These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 26428350)
1. The Stressors and Coping Strategies of Older Adults With Persistent Atrial Fibrillation Prior to and Following Direct Current Cardioversion. Rush KL; Hatt L; Shay M; Gorman N; Laberge CG; Reid RC; Wilson R J Appl Gerontol; 2017 Sep; 36(9):1145-1165. PubMed ID: 26428350 [TBL] [Abstract][Full Text] [Related]
2. 'It's like a frog leaping about in your chest': Illness and treatment perceptions in persistent atrial fibrillation. Taylor EC; O'Neill M; Hughes LD; Carroll S; Moss-Morris R Br J Health Psychol; 2018 Feb; 23(1):3-21. PubMed ID: 28875586 [TBL] [Abstract][Full Text] [Related]
3. Illness perceptions, coping strategies, and symptoms contribute to psychological distress in patients with recurrent symptomatic atrial fibrillation. McCabe PJ; Barnason SA J Cardiovasc Nurs; 2012; 27(5):431-44. PubMed ID: 21743342 [TBL] [Abstract][Full Text] [Related]
4. Perceived heart rhythm in relation to ECG findings after direct current cardioversion of atrial fibrillation. Nergårdh A; Frick M Heart; 2006 Sep; 92(9):1244-7. PubMed ID: 16547207 [TBL] [Abstract][Full Text] [Related]
5. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study. Wozakowska-Kapłon B; Opolski G Int J Cardiol; 2004 Aug; 96(2):171-6. PubMed ID: 15262030 [TBL] [Abstract][Full Text] [Related]
6. Prediction of sinus rhythm maintenance following DC-cardioversion of persistent atrial fibrillation - the role of atrial cycle length. Meurling CJ; Roijer A; Waktare JE; Holmqvist F; Lindholm CJ; Ingemansson MP; Carlson J; Stridh M; Sörnmo L; Olsson SB BMC Cardiovasc Disord; 2006 Mar; 6():11. PubMed ID: 16533393 [TBL] [Abstract][Full Text] [Related]
7. Comparison of atrial fibrillation recurrence rates after successful electrical cardioversion in patients with hyperthyroidism-induced versus non-hyperthyroidism-induced persistent atrial fibrillation. Siu CW; Jim MH; Zhang X; Chan YH; Pong V; Kwok J; Kung AW; Lau CP; Tse HF Am J Cardiol; 2009 Feb; 103(4):540-3. PubMed ID: 19195517 [TBL] [Abstract][Full Text] [Related]
8. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome. Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088 [TBL] [Abstract][Full Text] [Related]
9. Demographic and clinical characteristics of patients with atrial fibrillation and cardioversion as planned therapeutic options in the International Registry on Cardioversion of Atrial Fibrillation RHYTHM-AF Polish substudy. Dąbrowski R; Opolski G; Włodarczyk P; Kiliszek M; Ponikowski P Kardiol Pol; 2014; 72(8):700-6. PubMed ID: 24671916 [TBL] [Abstract][Full Text] [Related]
10. Influence of diabetes on the maintenance of sinus rhythm after a successful direct current cardioversion in patients with atrial fibrillation. Soran H; Younis N; Currie P; Silas J; Jones IR; Gill G QJM; 2008 Mar; 101(3):181-7. PubMed ID: 18202088 [TBL] [Abstract][Full Text] [Related]
11. The predictive value of plasma brain natriuretic peptide for the recurrence of atrial fibrillation six months after external cardioversion. Ari H; Binici S; Ari S; Akkaya M; Koca V; Bozat T; Gürdoğan M Turk Kardiyol Dern Ars; 2008 Oct; 36(7):456-60. PubMed ID: 19155659 [TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic peptide before and after cardioversion of persistent atrial fibrillation. Wozakowska-Kapłon B; Opolski G; Janion M Kardiol Pol; 2003 Apr; 58(4):255-63. PubMed ID: 14517556 [TBL] [Abstract][Full Text] [Related]
14. Doppler echocardiographic prediction of recurrent atrial fibrillation following cardioversion. Spiecker M; Böhm S; Börgel J; Grote J; Görlitz S; Huesing A; Mügge A Int J Cardiol; 2006 Nov; 113(2):161-6. PubMed ID: 16330115 [TBL] [Abstract][Full Text] [Related]
15. Association between Doppler flow of atrial fibrillatory contraction and recurrence of atrial fibrillation after electrical cardioversion. Kim H; Lee JP; Yoon HJ; Park HS; Cho YK; Nam CW; Hur SH; Kim YN; Kim KB J Am Soc Echocardiogr; 2014 Oct; 27(10):1107-12. PubMed ID: 24984584 [TBL] [Abstract][Full Text] [Related]
16. Long-term omega-3 polyunsaturated fatty acid supplementation reduces the recurrence of persistent atrial fibrillation after electrical cardioversion. Kumar S; Sutherland F; Morton JB; Lee G; Morgan J; Wong J; Eccleston DE; Voukelatos J; Garg ML; Sparks PB Heart Rhythm; 2012 Apr; 9(4):483-91. PubMed ID: 22120130 [TBL] [Abstract][Full Text] [Related]
17. Improvement in exercise performance after successful cardioversion in patients with persistent atrial fibrillation and symptoms of heart failure. Wozakowska-Kapłon B; Opolski G Kardiol Pol; 2003 Sep; 59(9):213-23. PubMed ID: 14618198 [TBL] [Abstract][Full Text] [Related]
19. Effect of early direct current cardioversion on the recurrence of atrial fibrillation in patients with persistent atrial fibrillation. Osmanagic A; Möller S; Osmanagic A; Sheta HM; Vinther KH; Egstrup K Am J Cardiol; 2015 Jul; 116(2):225-9. PubMed ID: 25972054 [TBL] [Abstract][Full Text] [Related]
20. Correlation between inflammation state and successful medical cardioversion using bepridil for refractory atrial fibrillation. Nishino M; Mori N; Nakamura D; Lee Y; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y J Cardiol; 2013 Aug; 62(2):117-20. PubMed ID: 23623817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]